Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins

Journal of Surgical Oncology

Volumn 82, Issue 2, 2003, Pages 104-110

  Pan, Wensheng ^a   Ishii, Hideaki ^a   Ebihara, Yoshiro ^a   Gobe, Glenda ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Bcl 2; E cadherin; Early gastric cancer; Ki 67; p53; ssDNA

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; SINGLE STRANDED DNA; UVOMORULIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURGERY; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER;

ADULT; AGED; APOPTOSIS; BIOLOGICAL MARKERS; CADHERINS; CELL ADHESION MOLECULES; CELL DIVISION; DNA, SINGLE-STRANDED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037309590     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10204     Document Type: Article

References (32)

1. Okamura T, Tsujitani S, Korenaga D, et al.: Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis. Am J Surg 1988;155:476-480.
2. Noguchi M, Miyazaki I: Extended lymph node dissection in gastrointestinal cancer. J Surg Oncol 1997;65:57-65.
3. Ohno S, Maehara Y, Ohiwa H, et al.: Peritoneal dissemination after a curative gastrectomy in patients with undifferentiated adenocarcinoma of the stomach. Semin Surg Oncol 1994;10:117-120.
4. Koufuji K, Takeda J, Toyonaga A, et al.: Early gastric cancer and lymph node metastasis. Kurume Med J 1997;44:157-164.
5. Noda H, Maehara Y, Irie K, et al.: Growth pattern and expressions of cell cycle regulator proteins p53 and p21WAF1/CIP1 in early gastric carcinoma. Cancer 2001;92:1828-1835.
6. Takizawa T, Koike M, Funada M, et al.: Histological variability of gastric carcinoma, with reference to biological behavior. Surg Ther 1997;77:29-36.
7. Japanese Gastric Cancer Association: "Japanese Classification of Gastric Carcinoma." 13th ed. Tokyo: Kanehara Ltd.; 1999. 22-27.
8. Kobayashi S, Iwase H, Kawarada Y, et al.: Detection of DNA fragmentation in human breast cancer tissue by an antibody specific to single-stranded DNA. Breast Cancer 1998;5:47-52.
9. Maeda M, Sugiyama T, Akai F, et al.: Single-stranded DNA as an immunocytochemical marker for apoptotic change of ischemia in gerbil hippocampus. Neurosci Lett 1998;240:69-72.
10. Takahashi Y, Mai M, Nishioka K: Alpha-difluoromethylonithine induces apoptosis as well as anti-angiogenesis in the inhibition of tumor growth and metastasis in human gastric cancer model. Int J Cancer 2000;85:243-247.
11. Mijic A, Ferencic Z, Belicza M, et al.: Apoptosis in human gastric polyps and adenocarcinomas: A stereological analysis. Hepatogastroenterology 1998;45:684-690.
12. Inada T, Ichikawa A, Igarashi S, et al.: Effect of preoperative 5-fluorouracil on apoptosis of advanced gastric cancer. J Surg Oncol 1997;65:106-110.
13. Ichiyoshi Y, Oiwa H, Tomisaki S, et al.: Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer. Hepatogastroenterology 1997;44:546-553.
14. Monig SP, Eidt S, Zirbes TK, et al.: p53 expression in gastric cancer: Clinicopathological correlation and prognostic significance. Dig Dis Sci 1997;42:2463-2467.
15. Ichiyoshi Y, Tomoda M, Tomisaki S, et al.: Macroscopic appearance and biological character of gastric cancer invading the muscularis propria. Hepatogastroenterology 1996;43:553-559.
16. Tsuji N, Ishiguro S, Suzuki N: Risk factors for lymph node metastases of intramucosal gastric cancer: A case-control study. Gastroenterol Endosc 1999;41:1059-1065.
17. Beckwith M, Ruscetti FW, Sing GK, et al.: Anti-IgM induces transforming growth factor-beta sensitivity in a human B-lymphoma cell line: Inhibition of growth is associated with a downregulation of mutant p53. Blood 1995;85:2461-2470.
18. Barbati A, Cosmi EV, Sidoni A, et al.: Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer. Anticancer Res 1997;17:401-405.
19. Soong R, Robbins PD, Dix BR, et al.: Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum Pathol 1996;27:1050-1055.
20. Hong SI, Hong WS, Jang JJ, et al.: Alterations of p53 gene in primary gastric cancer tissues. Anticancer Res 1994;14:1251-1255.
21. Kaibara N, Kimura O, Nishidoi H, et al.: High incidence of liver metastasis in gastric cancer with medullary growth pattern. J Surg Oncol 1985;28:195-198.
22. Yu J, Ebert MP, Miehlke S, et al.: Alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives. Gut 2000;46:639-644.
23. Shino Y, Watanabe A, Yamada Y, et al.: Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer 1995;76:2193-2201.
24. Takeichi M: Cadherins: A molecular family important in selective cell-cell adhension. Annu Rev Biochem 1990;59:237-252.
25. Liu J, Ikeguchi M, Nakamura S, et al.: Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: The relationship with patient survival. J Exp Clin Cancer Res 2002;21:65-71.
26. Bergin E, Levine JS, Koh JS, et al.: Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism. Am J Physiol 2000;278:F758-F768.
27. Day ML, Zhao X, Vallorosi CJ, et al.: E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway. J Biol Chem 1999;274:9656-9664.
28. Oda K, Yokoi S, Kanda H, et al.: Determination of growth fraction index in mammary carcinoma using MIB-1 monoclonal antibody: Estimation of whole tumor proliferative potential using biopsy specimens. Tokai J Exp Clin Med 1995;20:81-88.
29. Kakeji Y, Korenaga D, Tsujitani S, et al.: Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer 1993;67:589-593.
30. Goishi H, Tanaka S, Haruma K, et al.: Predictive value of cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer. Oncol Rep 2000;7:713-718.
31. Kanai T, Konno H, Maruyama K, et al.: p53 overexpression and proliferative activity do not correlate with lymph node metastasis in early gastric cancer. Eur Surg Res 1997;29:35-41.
32. Ono H, Kondo H, Gotoda T, et al.: Enodoscopic mucosal resection for treatment of early gastric cancer. Gut 2001;48:225-229.